 |
 |
Learn more about our hours of operation, our locations:
|
|
 |
|
Holston Medical Group is known across the nation for excellence in clinical research. Today, the HMG Clinical Research team consists of more than two dozen professionals, including principal investigators, RNs, LPNs, medical assistants and medical laboratory technicians. HMG actively participates in Phase II, Phase III and Phase IV clinical research studies.
For you, our patient, this means that our physicians are on the leading-edge of scientific research, participating in clinical trials that promise of medical breakthroughs in the treatment of a host of diseases and conditions.
To learn more about HMG Clinical Research, read the HMG Health Line magazine article, "Breaking Ground for Good."
Patient Participation
Since HMG Clinical Research's inception, more than 1,800 HMG patients have participated in clinical research studies.
Typically, the average study involves a patient commitment of approximately one year, with study visits ranging from weekly to bi-weekly. During these visits (averaging 15 minutes to an hour), patients receive attentive care by experienced clinical research coordinators (directed by an HMG physician principal investigator). All clinical research team members adhere to the rigorous guidelines established by the Institutional Review Board.
Clinical study participants are compensated for their time by the trial sponsor (compensation ranges from $10 to $100 per visit, depending upon the time commitment and type of visit) and receive all trial-related medication and monitoring as a complimentary safety measure.
For more information or to learn of HMG Clinical Research trials, please talk with your HMG primary care provider or call HMG Clinical Research at (423) 578-1506.
Pharmaceutical Partners
With leading pharmaceutical partners such as Merck, Hoffman LaRoche, Pfizer and Glaxo-Smith-Kline, HMG Clinical Research has developed a reputation of excellence. Since it's inception in 1996, HMG Clinical Research has worked with nearly 100 clinical research pharmaceutical partners in conducting more than 500 clinical trial studies.
A Drug's Long Road to Market
A great deal of advance research is conducted before a drug is ready for the lengthy clinical trial phases of development. First, potential drugs have to be discovered, purified, characterized, and tested in labs (in cell and animal studies) prior to ever beginning the clinical trial process. On average, a new cancer drug has at least six years of research behind it before it even makes it to the clinical trial phase. Then, once there, on average about eight years pass from the time the drug enters the clinical trial process until it receives approval from regulatory agencies for sale to the public.
|